
Marshall Wace’s 10x Genomics TXG Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.63M | Sell |
399,702
-17,749
| -4% | -$206K | 0.01% | 1081 |
|
2025
Q1 | $3.64M | Buy |
417,451
+370,590
| +791% | +$3.24M | ﹤0.01% | 1121 |
|
2024
Q4 | $673K | Sell |
46,861
-420,262
| -90% | -$6.03M | ﹤0.01% | 1785 |
|
2024
Q3 | $10.5M | Buy |
467,123
+431,722
| +1,220% | +$9.75M | 0.01% | 681 |
|
2024
Q2 | $689K | Buy |
+35,401
| New | +$689K | ﹤0.01% | 1662 |
|
2024
Q1 | – | Sell |
-7,516
| Closed | -$421K | – | 2481 |
|
2023
Q4 | $421K | Buy |
+7,516
| New | +$421K | ﹤0.01% | 1487 |
|
2023
Q3 | – | Sell |
-197,321
| Closed | -$11M | – | 2334 |
|
2023
Q2 | $11M | Buy |
+197,321
| New | +$11M | 0.02% | 599 |
|
2023
Q1 | – | Sell |
-19,268
| Closed | -$702K | – | 2602 |
|
2022
Q4 | $702K | Buy |
+19,268
| New | +$702K | ﹤0.01% | 1703 |
|
2022
Q1 | – | Sell |
-9,704
| Closed | -$1.45M | – | 3332 |
|
2021
Q4 | $1.45M | Sell |
9,704
-287,639
| -97% | -$42.9M | ﹤0.01% | 1753 |
|
2021
Q3 | $43.3M | Buy |
+297,343
| New | +$43.3M | 0.18% | 82 |
|
2021
Q1 | – | Sell |
-257,149
| Closed | -$36.4M | – | 2527 |
|
2020
Q4 | $36.4M | Buy |
257,149
+165,325
| +180% | +$23.4M | 0.2% | 90 |
|
2020
Q3 | $11.4M | Buy |
91,824
+72,924
| +386% | +$9.09M | 0.07% | 236 |
|
2020
Q2 | $1.69M | Sell |
18,900
-39,859
| -68% | -$3.56M | 0.01% | 824 |
|
2020
Q1 | $3.66M | Buy |
+58,759
| New | +$3.66M | 0.04% | 455 |
|